Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia. Abbasi J. JAMA 2022;327:310-312.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abbasi J. Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia. JAMA 2022;327:310-312.
PMID: 34985504